Kulkarni Samarth's Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Mar 12, 2025
- Accession no.
- 0000950170-25-038216
- Filed
- Mar 12, 2025
- Trade date
- Mar 10-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $616.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni SamarthCIK 0001682019 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Shares | MOption exerciseAcquired | +19,250 | – | – | 190,863 | Direct | |
| Mar 11, 2025 | Common Shares | SSaleDisposed | −9,973 | $42.42 | −$423,054.66 | 180,890 | Direct | |
| Mar 11, 2025 | Common Shares | MOption exerciseAcquired | +9,000 | – | – | 189,890 | Direct | |
| Mar 12, 2025 | Common Shares | SSaleDisposed | −4,462 | $43.32 | −$193,293.84 | 185,428 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Shares | MOption exerciseDisposed | −19,250 | – | – | 38,500 | Direct | |
| Mar 11, 2025 | Common Shares | MOption exerciseDisposed | −9,000 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.